'Medicare-for-All' is a pipe dream, but here's why it matters for healthcare stocks

A recent poll on "Medicare for All" — and commercial major medical insurance for none — showed a laughable 25% approval. Even worse for proponents, this poll was taken on stage at the first round of presidential debates in late June. Just five of 20 Democratic candidates had the nerve to raise their hands in support of this sweeping health care reform.